Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma.

Tang XX, Zhao H, Robinson ME, Cnaan A, London W, Cohn SL, Cheung NK, Brodeur GM, Evans AE, Ikegaki N.

Med Pediatr Oncol. 2000 Dec;35(6):656-8.

PMID:
11107140
2.

High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.

Tang XX, Evans AE, Zhao H, Cnaan A, London W, Cohn SL, Brodeur GM, Ikegaki N.

Clin Cancer Res. 1999 Jun;5(6):1491-6.

3.

Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.

Tang XX, Zhao H, Robinson ME, Cohen B, Cnaan A, London W, Cohn SL, Cheung NK, Brodeur GM, Evans AE, Ikegaki N.

Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10936-41.

4.

Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.

Tang XX, Evans AE, Zhao H, Cnaan A, Brodeur GM, Ikegaki N.

Med Pediatr Oncol. 2001 Jan;36(1):80-2.

PMID:
11464911
5.
6.

Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification.

Eggert A, Ho R, Ikegaki N, Liu XG, Brodeur GM.

Med Pediatr Oncol. 2000 Dec;35(6):623-7.

PMID:
11107132
7.

De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.

Ikegaki N, Gotoh T, Kung B, Riceberg JS, Kim DY, Zhao H, Rappaport EF, Hicks SL, Seeger RC, Tang XX.

Clin Cancer Res. 2007 Oct 15;13(20):6001-9.

8.

Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.

Helbling PM, Saulnier DM, Robinson V, Christiansen JH, Wilkinson DG, Brändli AW.

Dev Dyn. 1999 Dec;216(4-5):361-73.

9.

Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.

Tachibana M, Tonomoto Y, Hyakudomi R, Hyakudomi M, Hattori S, Ueda S, Kinugasa S, Yoshimura H.

Dig Liver Dis. 2007 Aug;39(8):725-32. Epub 2007 Jul 3.

PMID:
17611172
10.

TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.

Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.

Cancer. 2004 Oct 15;101(8):1873-81.

11.

Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma.

Fukahori S, Yano H, Tsuneoka M, Tanaka Y, Yagi M, Kuwano M, Tajiri T, Taguchi T, Tsuneyoshi M, Kojiro M.

J Pediatr Surg. 2007 Nov;42(11):1831-40.

PMID:
18022432
12.

Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6.

Munthe E, Rian E, Holien T, Rasmussen A, Levy FO, Aasheim H.

FEBS Lett. 2000 Jan 21;466(1):169-74.

13.

Coexpression of ephrin-Bs and their receptors in colon carcinoma.

Liu W, Ahmad SA, Jung YD, Reinmuth N, Fan F, Bucana CD, Ellis LM.

Cancer. 2002 Feb 15;94(4):934-9.

14.

Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.

Kramer K, Gerald W, LeSauteur L, Uri Saragovi H, Cheung NK.

Clin Cancer Res. 1996 Aug;2(8):1361-7.

16.

Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma.

Tang XX, Robinson ME, Riceberg JS, Kim DY, Kung B, Titus TB, Hayashi S, Flake AW, Carpentieri D, Ikegaki N.

Clin Cancer Res. 2004 Sep 1;10(17):5837-44.

17.

Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma.

Shimada A, Hirato J, Kuroiwa M, Kikuchi A, Hanada R, Wakai K, Hayashi Y.

Pediatr Blood Cancer. 2008 Feb;50(2):213-7.

PMID:
17941064
18.

Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer.

Takai N, Miyazaki T, Fujisawa K, Nasu K, Miyakawa I.

Oncol Rep. 2001 May-Jun;8(3):567-73.

PMID:
11295082
19.

Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.

Kogner P, Barbany G, Björk O, Castello MA, Donfrancesco A, Falkmer UG, Hedborg F, Kouvidou H, Persson H, Raschella G, et al.

Prog Clin Biol Res. 1994;385:137-45.

PMID:
7972205
20.

Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.

George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT.

J Clin Oncol. 2005 Sep 20;23(27):6466-73. Epub 2005 Aug 22.

PMID:
16116152

Supplemental Content

Support Center